ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcript

And if they have that to offer the plastics clips, which are fully available on ResMed masks as an alternative to our mass with magnets. The masks with magnets are so convenient. They’re doing so well and for 99% of people, they’re great. For that 1%, the HMEs are very comfortable now to ask those questions. And the other 140 countries we are working through the appropriate ways to ask the questions and get people the best mask and have the best fit and drive the best adherence over time. But they had no impact on the quarterly sales whatsoever. And we don’t expect an impact going forward because this was an upgrade to a labeling that was actually in line with clinical practice over the last 12 months. And it just makes sense to do that. Thanks a lot for the question, Michael.

Operator: Thank you. We reached the end of our question-and-answer session. I’d like to turn the floor back over to Mick for any further or closing comments.

Michael Farrell: Thanks, Kevin, and thank you again to all of our stakeholders for joining us on this call. The opportunity in front of us is huge and largely untapped. It’s an incredible runway. We see more and more people coming into the health care system, and this will benefit us as we seek to help them sleep better, breathe better and live better lives in 140 countries. Thank you to all 10,000 ResMedians. Many of you are also shareholders for what you do today and every day. With that, I’ll hand the call back to Amy to close this out.

Amy Wakeham: Great. Thank you, Mick. Thanks, everyone, for listening. We do appreciate your time and your interest. If you have any additional questions, please don’t hesitate to reach out directly. This does conclude our second quarter 2024 conference call. Kevin, you can go ahead and close this out.

Operator: Thank you. That does conclude today’s teleconference and webcast. You may disconnect your line at this time, and have a wonderful day. We thank you for your participation today.